|
Q1 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Jun 30, 2026
|
Q3 FY2026
As of Jan 31, 2026
|
Q2 FY2026
As of Oct 31, 2025
|
Q1 FY2026
As of Jul 31, 2025
|
Q4 FY2025
As of Apr 30, 2025
|
Q3 FY2025
As of Jan 31, 2025
|
Q2 FY2025
As of Oct 31, 2024
|
Q1 FY2025
As of Jul 31, 2024
|
Q4 FY2024
As of Apr 30, 2024
|
Q3 FY2024
As of Jan 31, 2024
|
Q2 FY2024
As of Oct 31, 2023
|
Q1 FY2024
As of Jul 31, 2023
|
Q4 FY2023
As of Apr 30, 2023
|
Q3 FY2023
As of Jan 31, 2023
|
Q2 FY2023
As of Oct 31, 2022
|
Q1 FY2023
As of Jul 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable | |||||||||||||||||
| Inventory, net | |||||||||||||||||
| Prepaid expenses | |||||||||||||||||
| Deferred offering costs | |||||||||||||||||
| Other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Capitalized software | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Right-of-use assets, net | |||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||
| CURRENT LIABILITIES | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued expenses | |||||||||||||||||
| Accrued interest expense | |||||||||||||||||
| Operating lease liabilities, current portion | |||||||||||||||||
| Current portion of notes payable | |||||||||||||||||
| Other current liabilities | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| LONG-TERM LIABILITIES | |||||||||||||||||
| Notes payable, long-term | |||||||||||||||||
| Accrued expenses | |||||||||||||||||
| Operating lease liabilities, long-term | |||||||||||||||||
| Total long-term liabilities | |||||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||||
| STOCKHOLDERS' (DEFICIT) EQUITY | |||||||||||||||||
| Preferred stock | |||||||||||||||||
| Series C Convertible Preferred Stock | |||||||||||||||||
| Series D Preferred Stock | |||||||||||||||||
| Series A, B and C Convertible Preferred Stock | |||||||||||||||||
| Series C Preferred Stock | |||||||||||||||||
| Series D Preferred Stock | |||||||||||||||||
| Common stock | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| TOTAL STOCKHOLDERS' (DEFICIT) EQUITY | |||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY | |||||||||||||||||
Loading...
